Active substance
Results for the substance metreleptin
3 results
About this active substance
Metreleptin is a leptin analog used for the treatment of congenital or acquired generalized lipodystrophy. This rare condition is characterized by severe loss of adipose tissue, leading to serious metabolic complications such as diabetes mellitus and hypertriglyceridemia.
Metreleptin helps regulate metabolism by replacing leptin, a hormone essential for appetite control and energy metabolism. Treatment with metreleptin can significantly improve blood glucose and lipid levels, reducing the risk of cardiovascular complications.
This medication is administered as a subcutaneous injection and is intended for use under the supervision of a specialist. It is contraindicated in patients with hypersensitivity to metreleptin or any of its excipients.
Although effective, metreleptin may have side effects, such as injection site reactions or the risk of developing neutralizing antibodies, which can reduce the treatment's efficacy.
Metreleptin helps regulate metabolism by replacing leptin, a hormone essential for appetite control and energy metabolism. Treatment with metreleptin can significantly improve blood glucose and lipid levels, reducing the risk of cardiovascular complications.
This medication is administered as a subcutaneous injection and is intended for use under the supervision of a specialist. It is contraindicated in patients with hypersensitivity to metreleptin or any of its excipients.
Although effective, metreleptin may have side effects, such as injection site reactions or the risk of developing neutralizing antibodies, which can reduce the treatment's efficacy.
-
-
MYALEPTA 5.8mg powder for solution for injection CHIESI ORIGINAL MEDICINE
-
MYALEPTA 3mg powder for solution for injection CHIESI ORIGINAL MEDICINE